Novocure Ltd Ord Sh (NVCR)
18.67 +0.23 (+1.25%) 10:38 ET [NASDAQ]
18.64 x 100 18.70 x 100
Realtime by (Cboe BZX)
18.64 x 100 18.70 x 100
Realtime - - (-) -
for Thu, Mar 27th, 2025
Results
download Want to compare other data? Select FieldsSymbol | NVCR | AZN | AMGN | GILD | VRTX |
Company | Novocure Ltd Ord Sh | Astrazeneca Plc ADR | Amgen Inc | Gilead Sciences Inc | Vertex Pharmaceutic |
Price Information | |||||
Exchange | NASDAQ | NASDAQ | NASDAQ | NASDAQ | NASDAQ |
Open | 18.52 | 72.43 | 306.22 | 110.00 | 498.59 |
High | 18.75 | 72.73 | 307.57 | 111.81 | 506.54 |
Low | 18.31 | 72.37 | 304.29 | 109.74 | 498.59 |
Last | 18.67 | 72.69 | 306.31 | 110.81 | 504.03 |
Change | +0.23 | -0.03 | +0.60 | +1.54 | +3.75 |
% Change | +1.25% | -0.04% | +0.20% | +1.41% | +0.75% |
Volume | 47,118 | 657,336 | 258,556 | 1,279,171 | 119,217 |
20-Day Average Volume | 919,325 | 5,565,728 | 3,038,652 | 10,692,458 | 1,343,031 |
Previous Close | 18.44 | 72.72 | 305.71 | 109.27 | 500.28 |
Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical |
Has Options | Yes | Yes | Yes | Yes | Yes |
Technicals | |||||
20-Day Moving Average | 19.42 | 75.85 | 314.62 | 112.10 | 499.15 |
20-Day Raw Stochastic | 31.99% | 11.63% | 12.00% | 40.37% | 64.68% |
20-Day Relative Strength | 37.63% | 44.53% | 51.49% | 56.96% | 58.33% |
Weighted Alpha | -16.71 | +3.46 | +6.93 | +59.69 | +20.69 |
Today's Opinion | 56% Sell | 8% Sell | 32% Buy | 80% Buy | 88% Buy |
Previous Opinion | 56% Sell | 24% Sell | 16% Buy | 80% Buy | 88% Buy |
Last Month's Opinion | 24% Buy | 24% Buy | 24% Buy | 100% Buy | 40% Buy |
Performance | |||||
5-Days | |||||
%Chg | -3.44% since 03/20/25 | -5.15% since 03/20/25 | -2.43% since 03/20/25 | +4.71% since 03/20/25 | -1.30% since 03/20/25 |
Low | 18.23 on 03/26/25 | 71.82 on 03/26/25 | 303.51 on 03/25/25 | 104.92 on 03/21/25 | 497.78 on 03/26/25 |
High | 19.97 on 03/24/25 | 75.90 on 03/21/25 | 317.58 on 03/24/25 | 111.81 on 03/27/25 | 513.97 on 03/24/25 |
1-Month | |||||
%Chg | -3.69% since 02/27/25 | -4.06% since 02/27/25 | +0.52% since 02/27/25 | -1.01% since 02/27/25 | +6.12% since 02/27/25 |
Low | 17.09 on 03/04/25 | 71.82 on 03/26/25 | 303.51 on 03/25/25 | 104.70 on 03/20/25 | 474.01 on 02/28/25 |
High | 21.55 on 03/12/25 | 78.36 on 03/05/25 | 335.88 on 03/10/25 | 119.96 on 03/10/25 | 519.68 on 03/14/25 |
3-Month | |||||
%Chg | -39.67% since 12/27/24 | +9.54% since 12/27/24 | +17.04% since 12/27/24 | +17.80% since 12/27/24 | +23.19% since 12/27/24 |
Low | 17.09 on 03/04/25 | 64.22 on 01/14/25 | 257.05 on 01/06/25 | 88.57 on 01/10/25 | 397.24 on 01/13/25 |
High | 31.17 on 01/02/25 | 78.36 on 03/05/25 | 335.88 on 03/10/25 | 119.96 on 03/10/25 | 519.68 on 03/14/25 |
6-Month | |||||
%Chg | +18.64% since 09/27/24 | -6.49% since 09/27/24 | -4.73% since 09/27/24 | +32.59% since 09/27/24 | +8.79% since 09/27/24 |
Low | 14.17 on 10/08/24 | 62.75 on 11/18/24 | 253.30 on 12/19/24 | 82.82 on 10/01/24 | 377.85 on 12/19/24 |
High | 34.13 on 12/18/24 | 79.76 on 10/02/24 | 335.88 on 03/10/25 | 119.96 on 03/10/25 | 519.88 on 11/08/24 |
Key Statistics | |||||
Market Capitalization, $K | 2,026,833 | 225,520,304 | 164,228,944 | 136,078,944 | 128,466,912 |
Shares Outstanding, K | 109,915 | 3,101,214 | 537,205 | 1,245,346 | 256,790 |
Annual Sales | 605,220,000 | 54,073,000,000 | 33,424,000,000 | 28,754,000,000 | 11,020,100,000 |
Annual Net Income | -168,630,000 | 7,035,000,000 | 4,090,000,000 | 480,000,000 | -535,600,000 |
Last Quarter Sales | 161,270,000 | 14,891,000,000 | 9,086,000,000 | 7,569,000,000 | 2,912,000,000 |
Last Quarter Net Income | -65,920,000 | 1,499,000,000 | 627,000,000 | 1,783,000,000 | 913,000,000 |
60-Month Beta | 0.63 | 0.41 | 0.53 | 0.21 | 0.41 |
Per-Share Information | |||||
Most Recent Earnings | -0.61 on 02/27/25 | 1.05 on 02/06/25 | 5.31 on 02/04/25 | 1.90 on 02/11/25 | 3.98 on 02/10/25 |
Latest Earnings Date | 05/01/25 | 04/24/25 | 05/01/25 | 04/24/25 | 05/05/25 |
Most Recent Dividend | N/A | 1.030 on 02/21/25 | 2.380 on 02/14/25 | 0.790 on 03/14/25 | N/A |
Next Ex-Dividends Date | N/A | 02/21/25 | 05/16/25 | 03/14/25 | N/A |
Ratios | |||||
Price/Earnings ttm | 0.00 | 17.77 | 15.48 | 23.40 | 0.00 |